Concord Biotech Limited (BOM:543960)
India flag India · Delayed Price · Currency is INR
1,637.35
+4.15 (0.25%)
At close: Aug 14, 2025

Concord Biotech Balance Sheet

Millions INR. Fiscal year is Apr - Mar.
Fiscal Year
TTM FY 2025 FY 2024 FY 2023 FY 2022 FY 2021 2020
Period Ending
Jun '25 Mar '25 Mar '24 Mar '23 Mar '22 Mar '21 2020
Cash & Equivalents
-9.05151.4234.996.6751.44
Upgrade
Short-Term Investments
-179.89228.22305.8872.5550
Upgrade
Trading Asset Securities
-3,1652,4371,369734.731,410
Upgrade
Cash & Short-Term Investments
3,1773,3542,8171,7101,6142,011
Upgrade
Cash Growth
12.80%19.09%64.71%5.96%-19.76%0.31%
Upgrade
Accounts Receivable
-5,2173,4962,7382,3221,775
Upgrade
Other Receivables
-210.46193.66217.95272.74358.19
Upgrade
Receivables
-5,4273,6902,9562,5942,133
Upgrade
Inventory
-2,3972,0802,1231,9511,536
Upgrade
Prepaid Expenses
-73.9173.3155.1947.6145.44
Upgrade
Other Current Assets
-100.48303.06433.05119.5345.27
Upgrade
Total Current Assets
-11,3528,9627,2776,3276,071
Upgrade
Property, Plant & Equipment
-8,4427,8657,6556,4365,577
Upgrade
Long-Term Investments
-227.8120.779.252.563.66
Upgrade
Other Intangible Assets
-11.223.21.9835.7764.18
Upgrade
Other Long-Term Assets
-308.86156.1126.8327.4108.69
Upgrade
Total Assets
-20,34317,00715,14013,12811,825
Upgrade
Accounts Payable
-1,130944.35938831.06463.97
Upgrade
Accrued Expenses
-192.07168.21146.19131.45102.38
Upgrade
Short-Term Debt
-3.81--43.3750.99
Upgrade
Current Portion of Long-Term Debt
--62.3250250250
Upgrade
Current Portion of Leases
-19.5816.211.4715.9613.01
Upgrade
Current Income Taxes Payable
-101.2754.9489.99--
Upgrade
Current Unearned Revenue
---13.1332.72-
Upgrade
Other Current Liabilities
-393.5175.55479.67247.1177.04
Upgrade
Total Current Liabilities
-1,8411,4221,9181,5521,057
Upgrade
Long-Term Debt
---62.36312.49562.5
Upgrade
Long-Term Leases
-6.318.871.643.1116.33
Upgrade
Long-Term Deferred Tax Liabilities
-340.22280.65234.39209.71174.53
Upgrade
Other Long-Term Liabilities
-28.219.5622.9718.7420.98
Upgrade
Total Liabilities
-2,2151,7412,2402,0961,832
Upgrade
Common Stock
-104.62104.62104.6295.1195.11
Upgrade
Additional Paid-In Capital
-819.71819.71819.71829.22829.22
Upgrade
Retained Earnings
-17,20314,34211,97610,1089,069
Upgrade
Shareholders' Equity
18,12718,12715,26612,90011,0329,994
Upgrade
Total Liabilities & Equity
-20,34317,00715,14013,12811,825
Upgrade
Total Debt
29.6929.6997.38315.46624.93892.83
Upgrade
Net Cash (Debt)
3,1483,3252,7191,395988.981,118
Upgrade
Net Cash Growth
15.75%22.26%94.98%41.02%-11.58%-24.66%
Upgrade
Net Cash Per Share
30.0831.7825.9913.339.4510.69
Upgrade
Filing Date Shares Outstanding
104.65104.62104.62104.62104.62104.62
Upgrade
Total Common Shares Outstanding
104.65104.62104.62104.62104.62104.62
Upgrade
Working Capital
-9,5127,5415,3594,7755,014
Upgrade
Book Value Per Share
173.28173.27145.93123.31105.4595.53
Upgrade
Tangible Book Value
18,11618,11615,26312,89810,9969,930
Upgrade
Tangible Book Value Per Share
173.18173.17145.90123.29105.1194.91
Upgrade
Land
-629.93547.11547.11547.11546.99
Upgrade
Buildings
-3,5532,5762,4632,2261,981
Upgrade
Machinery
-6,6224,9794,7884,2853,773
Upgrade
Construction In Progress
-501.312,1151,727741.55179.46
Upgrade
Source: S&P Global Market Intelligence. Standard template. Financial Sources.